Genotyped versus phenotyped dosing to account for UGT polymorphism of the novel PPAR agonist sipoglitazar

Therapeutic area :

Stringer  F., Ploeger B., Jongh J.d., Scott G., Urquart R., Karim A. and Danhof M., Genotyped versus phenotyped dosing to account for UGT polymorphism of the novel PPAR agonist sipoglitazar PAGE.(2009). [Link to publication]